{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T22:37:29Z","timestamp":1720823849908},"reference-count":19,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.gastrohep.2011.04.001","type":"journal-article","created":{"date-parts":[[2011,7,6]],"date-time":"2011-07-06T04:56:02Z","timestamp":1309928162000},"page":"443-448","source":"Crossref","is-referenced-by-count":23,"title":["Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experience"],"prefix":"10.1016","volume":"34","author":[{"given":"Jos\u00e9 Ignacio","family":"Fortea-Ormaechea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yago","family":"Gonz\u00e1lez-Lama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bego\u00f1a","family":"Casis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Chaparro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"L\u00f3pez Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Van Domselaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Bermejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram\u00f3n","family":"Pajares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel","family":"Ponferrada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Isabel","family":"Vera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Mart\u00ednez Montiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier P.","family":"Gisbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"P\u00e9rez-Calle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"L\u00f3pez San Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Alberto","family":"Mench\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Mar\u00edn-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2011.04.001_bib0005","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.3748\/wjg.14.5523","article-title":"Are we giving biologics too late? The case for early versus late use","volume":"14","author":"Ricart","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2011.04.001_bib0010","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.cgh.2008.03.014","article-title":"Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials","volume":"6","author":"Peyrin-Biroulet","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2011.04.001_bib0015","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/ajg.2008.88","article-title":"Loss of response and requirement of infliximab dose intensification in Crohn's disease: a review","volume":"104","author":"Gisbert","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2011.04.001_bib0020","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.2165\/00003495-200464160-00004","article-title":"Managing immunogenic responses to infliximab: treatment implications for patients with Crohn's disease","volume":"64","author":"Han","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.gastrohep.2011.04.001_bib0025","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2005.11.030","article-title":"Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial","volume":"130","author":"Hanauer","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2011.04.001_bib0030","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2006.11.041","article-title":"Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial","volume":"132","author":"Colombel","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2011.04.001_bib0035","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1136\/gut.2006.106781","article-title":"Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial","volume":"56","author":"Sandborn","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2011.04.001_bib0040","doi-asserted-by":"crossref","first-page":"829","DOI":"10.7326\/0003-4819-146-12-200706190-00159","article-title":"Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial","volume":"146","author":"Sandborn","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.gastrohep.2011.04.001_bib0045","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1053\/j.gastro.2008.07.069","article-title":"Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study","volume":"135","author":"Feagan","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2011.04.001_bib0050","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/gut.2008.159251","article-title":"Adalimumab for the treatment of fistulas in patients with Crohn's disease","volume":"58","author":"Colombel","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2011.04.001_bib0055","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2036.2006.03232.x","article-title":"Efficacy and safety of short-term adalimumab treatment in patients with active Crohn's disease who lost response or showed intolerance to infliximab: a prospective, open-label, multicentre trial","volume":"25","author":"Hinojosa","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2011.04.001_bib0060","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2036.2007.03254.x","article-title":"Adalimumab maintenance therapy for Crohn's disease with intolerance or lost response to infliximab: an open-label study","volume":"25","author":"Peyrin-Biroulet","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2011.04.001_bib0065","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1572-0241.2005.40647.x","article-title":"Safety and efficacy of adalimumab (D2E7) in Crohn's disease patients with an attenuated response to infliximab","volume":"100","author":"Papadakis","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2011.04.001_bib0070","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00054725-200407000-00002","article-title":"A pilot study of adalimumab in infliximab-allergic patients","volume":"10","author":"Youdim","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2011.04.001_bib0075","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1111\/j.1572-0241.2004.40462.x","article-title":"An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's disease","volume":"99","author":"Sandborn","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2011.04.001_bib0080","first-page":"676","article-title":"Adalimumab induction and maintenance therapy for Crohn's disease. An open-label study","volume":"100","author":"L\u00f3pez Palacios","year":"2008","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.gastrohep.2011.04.001_bib0085","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1365-2036.2007.03583.x","article-title":"The use of adalimumab in the management of refractory Crohn's disease","volume":"27","author":"Ho","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2011.04.001_bib0090","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2036.2008.03919.x","article-title":"Efficacy and complications of adalimumab treatment for medically-refractory Crohn's disease: analysis of nationwide experience in Scotland (2004-2008)","volume":"29","author":"Ho","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2011.04.001_bib0095","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2036.2008.03878.x","article-title":"Early clinical experience with adalimumab in treatment of inflammatory bowel disease with infliximab-treated and na\u00efve patients","volume":"29","author":"Swaminath","year":"2009","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570511001981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570511001981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T12:26:03Z","timestamp":1543667163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210570511001981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0210570511001981"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2011.04.001","relation":{},"ISSN":["0210-5705"],"issn-type":[{"value":"0210-5705","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}